U.S., March 17 -- ClinicalTrials.gov registry received information related to the study (NCT07475546) titled 'Combination Gerotherapeutic Interventions for Healthspan Improvement' on Feb. 02.
Brief Summary: This study is a 90-day interventional, randomized, controlled pilot trial exploring multi-modal gerotherapies and their impact on longevity-related outcomes. In this proof-of-concept phase, a small sample size of up to 30 subjects (10 subjects in each arm) will be randomized into one of the three arms: 1) Control, 2) Multi-therapy (B12, Naltrexone, Metformin, and NAD+), or 4) Comprehensive Therapy (Rapamycin, Naltrexone, Metformin, B12, NAD+, GSH, and Infinite Supplement).
Study Start Date: July 23, 2025
Study Type: INTERVENTIONAL
Co...